A detailed history of Franklin Resources Inc transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 167,184 shares of AKBA stock, worth $314,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167,184
Previous 167,184 -0.0%
Holding current value
$314,305
Previous $220,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.94 - $1.55 $157,152 - $259,135
167,184 New
167,184 $220,000
Q3 2023

Nov 13, 2023

SELL
$0.87 - $1.84 $15,129 - $31,997
-17,390 Reduced 21.09%
65,083 $74,000
Q2 2022

Aug 11, 2022

SELL
$0.32 - $0.67 $12,775 - $26,747
-39,922 Reduced 32.62%
82,473 $29,000
Q1 2022

May 13, 2022

BUY
$0.72 - $2.93 $501 - $2,042
697 Added 0.57%
122,395 $88,000
Q4 2021

Feb 11, 2022

SELL
$2.26 - $3.34 $682 - $1,008
-302 Reduced 0.25%
121,698 $275,000
Q3 2021

Nov 12, 2021

BUY
$2.35 - $3.88 $286,700 - $473,360
122,000 New
122,000 $351,000

Others Institutions Holding AKBA

About Akebia Therapeutics, Inc.


  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $346M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.